Effect of cupric sulfate on the prophylactic efficacy of 2-acetylamino-5nitrothiazole, nifursol and ipronidazole against histomoniasis in turkeys.
D000081:Acetamides / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D000818:Animals; D000981:Antiprotozoal Agents / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D003300:Copper / Q000494:pharmacology*; D006834:Hydrazines / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D007093:Imidazoles / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D009574:Nitro Compounds / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D009581:Nitrofurans / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D011201:Poultry Diseases / Q000188:drug therapy / Q000517:prevention & control*; D011528:Protozoan Infections / Q000188:drug therapy / Q000517:prevention & control*; D012459:Salicylates / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D013431:Sulfates / Q000494:pharmacology*; D013844:Thiazoles / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D014422:Turkeys
D000081:Acetamides; D000981:Antiprotozoal Agents; D006834:Hydrazines; D007093:Imidazoles; D009574:Nitro Compounds; D009581:Nitrofurans; D012459:Salicylates; D013431:Sulfates; D013844:Thiazoles; D003300:Copper